Metrics as of 10/16/2026, 08:42 AM (Berlin time), refresh in progress.
Hemogenyx Pharmaceuticals Stock
Hemogenyx Pharmaceuticals Plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Vladislav Sandler
- Employees
- 16
- Market cap
- £45 M
- IPO
- 09/11/2015
Hemogenyx Pharmaceuticals Plc is a preclinical biotechnology company dedicated to the discovery, advancement, and commercialization of innovative therapies for various blood diseases. The firm's pipeline is heavily focused on creating novel solutions for the bone marrow and hematopoietic stem cell (BM/HSC) transplant…
Hemogenyx Pharmaceuticals stock: price history
1D
+7.2%
1W
-10.5%
1M
+44.6%
6M
-26.9%
YTD
+15.0%
1Y
-33.5%
2Y
+46.2%
5Y
-20.7%
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~32% weaker price swings than usual
Ask the agents about Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals stock metrics
P/E
-3.64
P/B
9.8
EV/EBITDA
-4.71
RETURN ON EQUITY
-151.5%
NET MARGIN
0.0%
DEBT/EQUITY
0.43
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
53.2%
FLOAT SHARES
3,667,617
AVG. DAILY VOLUME (30D)
31,747
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Hemogenyx Pharmaceuticals stock
What does Hemogenyx Pharmaceuticals do?
Hemogenyx Pharmaceuticals Plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Vladislav Sandler, the company employs around 16 people.
The IPO was on 09/11/2015; the stock trades on LSE under the ticker HEMO.L.
When does Hemogenyx Pharmaceuticals report next?
Around past earnings, price swings were roughly -32% stronger than usual.
Does Hemogenyx Pharmaceuticals pay a dividend?
No, Hemogenyx Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to Hemogenyx Pharmaceuticals?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Hemogenyx Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Hemogenyx Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.